成大生物
(688739)
| 流通市值：110.44亿 | | | 总市值：110.44亿 |
| 流通股本：4.16亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,010,183,067.13 | 3,653,579,439.58 | 3,961,121,082.99 | 4,496,464,173.92 |
| 交易性金融资产 | 1,059,830,646.57 | 1,412,601,101.37 | 1,445,184,692.08 | 973,022,898.61 |
| 应收票据及应收账款 | 1,170,186,665.95 | 1,150,671,673.92 | 1,125,375,730.04 | 1,076,901,537.54 |
| 应收账款 | 1,170,186,665.95 | 1,150,671,673.92 | 1,125,375,730.04 | 1,076,901,537.54 |
| 预付款项 | 30,982,973.28 | 25,836,400.52 | 27,434,142.69 | 23,688,069.38 |
| 其他应收款合计 | 1,980,736.56 | 1,483,387.27 | 1,470,996.83 | 1,410,319.73 |
| 存货 | 460,177,712.38 | 463,138,946.84 | 445,146,367.44 | 459,942,981.39 |
| 其他流动资产 | 36,878,856.53 | 60,868,170.57 | 68,146,624.57 | 51,903,309.34 |
| 流动资产合计 | 6,770,220,658.4 | 6,768,179,120.07 | 7,073,879,636.64 | 7,083,333,289.91 |
| 非流动资产: | | | | |
| 长期股权投资 | 55,614,556.36 | 56,172,924.21 | 56,932,058.2 | 56,896,560 |
| 其他非流动金融资产 | 71,834,730.98 | 72,910,065.69 | 75,478,021.07 | 75,478,021.07 |
| 固定资产 | 1,403,540,340.02 | 1,392,411,932.16 | 1,437,017,436.1 | 1,480,092,317.43 |
| 在建工程 | 499,886,080.03 | 514,254,446.35 | 506,935,671.64 | 465,579,320.09 |
| 使用权资产 | 11,600,527.38 | 12,826,358.79 | 14,052,190.2 | 15,278,021.61 |
| 无形资产 | 184,109,159.58 | 182,710,761.26 | 185,743,706.56 | 181,452,488.18 |
| 开发支出 | 674,074,166.72 | 646,478,230.54 | 609,663,201.03 | 574,698,171.48 |
| 长期待摊费用 | 10,738,386.35 | 11,772,950.48 | 12,807,514.61 | 13,842,078.74 |
| 递延所得税资产 | 48,713,280.4 | 47,357,280.1 | 41,054,299.19 | 35,717,812.05 |
| 其他非流动资产 | 72,422,392.29 | 81,481,742.9 | 67,059,680.94 | 69,219,185.75 |
| 非流动资产合计 | 3,032,533,620.11 | 3,018,376,692.48 | 3,006,743,779.54 | 2,968,253,976.4 |
| 资产总计 | 9,802,754,278.51 | 9,786,555,812.55 | 10,080,623,416.18 | 10,051,587,266.31 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 218,300,717.14 | 218,393,550.18 | 267,107,833.69 | 252,021,553.48 |
| 应付账款 | 218,300,717.14 | 218,393,550.18 | 267,107,833.69 | 252,021,553.48 |
| 合同负债 | 96,330.29 | 3,752,865.14 | 390,439.45 | 3,648,092.15 |
| 应付职工薪酬 | 94,322,008.36 | 81,735,593.75 | 71,051,803.34 | 122,837,222.65 |
| 应交税费 | 7,076,776.43 | 8,286,369.76 | 7,404,663 | 8,800,252.87 |
| 其他应付款合计 | 2,441,177.76 | 2,478,388.76 | 2,145,801.23 | 858,900 |
| 应付股利 | 465,900.96 | 465,900.96 | 381,900 | 381,900 |
| 一年内到期的非流动负债 | 5,055,820.51 | 5,390,788.91 | 5,216,607.36 | 5,139,220.8 |
| 其他流动负债 | - | 1,092.09 | 986.68 | 1,515.35 |
| 流动负债合计 | 327,292,830.49 | 320,038,648.59 | 353,318,134.75 | 393,306,757.3 |
| 非流动负债: | | | | |
| 租赁负债 | 7,161,557.81 | 7,121,932.65 | 9,482,718.36 | 10,002,268.69 |
| 预计负债 | 3,066,237.91 | 23,405,975.42 | - | - |
| 递延收益 | 77,855,175 | 80,438,270.49 | 83,021,365.98 | 85,604,461.47 |
| 递延所得税负债 | 190,292.55 | 90,439.84 | 112,140.73 | 194,295.74 |
| 其他非流动负债 | 7,700 | 6,200 | 3,100 | 11,532 |
| 非流动负债合计 | 88,280,963.27 | 111,062,818.4 | 92,619,325.07 | 95,812,557.9 |
| 负债合计 | 415,573,793.76 | 431,101,466.99 | 445,937,459.82 | 489,119,315.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,450,000 | 416,450,000 | 416,450,000 | 416,450,000 |
| 资本公积 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 |
| 减:库存股 | 160,784,053.11 | 149,992,850 | 149,992,850 | 149,992,850 |
| 盈余公积 | 208,225,000 | 208,225,000 | 208,225,000 | 208,225,000 |
| 未分配利润 | 3,889,115,418.32 | 3,846,598,076.02 | 4,125,829,686.82 | 4,053,611,681.57 |
| 归属于母公司股东权益合计 | 9,387,180,484.75 | 9,355,454,345.56 | 9,634,685,956.36 | 9,562,467,951.11 |
| 股东权益合计 | 9,387,180,484.75 | 9,355,454,345.56 | 9,634,685,956.36 | 9,562,467,951.11 |
| 负债和股东权益合计 | 9,802,754,278.51 | 9,786,555,812.55 | 10,080,623,416.18 | 10,051,587,266.31 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-30 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |